Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RX-10045 in Dry Eye Disease
NCT01675570Phase 2Completed
- Sponsor
- C.T. Development America
- Start
- Aug 2012
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of navamepent in dry eye syndrome (DED), sponsored by C.T. Development America. Started Aug 2012; status: completed.
02
Drugs
navamepent
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT01675570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01675570.